Last updated on January 2019

A Washington University research study seeks participants with spinal muscular atrophy (SMA).

Brief description of study

The purpose of this study is to measure the safety, tolerability, and effectiveness of SPINRAZA® in adults with spinal muscular atrophy (SMA).

There up to 12 study visits. Participation includes a physical and neurological exam, blood tests, questionnaires, and study related assessments. Up to $600.00 is provided for time and effort (IRB # 201805187)


Clinical Study Identifier: TX217961

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.